Skip to content
glp1.howSign in

Supportive Health

Hormone replacement therapy (HRT) and GLP-1 medications: an overview

HRT and GLP-1s keep coming up together because the times people look at hormones (menopause in women, low testosterone in men) are also times of weight and body-composition change. This overview explains what each does, who benefits, what weight loss does to testosterone, and how to plan the two together.

By the glp1.how editorial teamReviewed 3 min read

Evidence-backed

Hormone replacement therapy (HRT) and GLP-1 medications do different things, but they keep coming up together because of timing. People tend to look at hormones around menopause (women) or when they find out they have low testosterone (men), and those are the same years when weight and body composition change and a GLP-1 comes up.

What "HRT" means here

For women, HRT means menopausal hormone therapy: estrogen, usually with a progestogen, to treat menopausal symptoms and protect bone. For men, it means testosterone replacement therapy (TRT) for diagnosed hypogonadism. Both replace a hormone the body is short on. Neither one is a weight-loss drug, and neither works like a GLP-1.

Who benefits

Women with moderate-to-severe menopausal symptoms, or who need bone protection, are the main candidates, and the decision depends on timing and personal risk. The details are in HRT for women and GLP-1 medications.

For men, the Endocrine Society's guideline recommends diagnosing hypogonadism only when there are symptoms and testosterone is clearly and consistently low on repeated morning tests (Bhasin et al., Journal of Clinical Endocrinology & Metabolism, 2018, DOI (external link)). Low testosterone that comes with obesity is often reversible without TRT. See HRT for men and GLP-1 medications.

Where GLP-1s come in

Menopause and obesity-related low testosterone both tend to add fat, especially visceral fat, and take away muscle. A GLP-1 works on that same problem through weight loss.

Weight loss also changes hormones. In men with obesity, losing weight through diet or surgery raises testosterone, and the more weight lost, the bigger the rise (Corona et al., European Journal of Endocrinology, 2013, DOI (external link)). There is now GLP-1-specific evidence too: a 2025 meta-analysis of seven studies (680 men with overweight or obesity) found GLP-1 treatment raised total testosterone, with larger rises in men who lost more weight (Salvio et al., Andrology, 2025, DOI (external link)). A 2025 clinical review explains why. Much of the low testosterone seen in obesity is a drop in its carrier protein (SHBG) with normal LH and FSH, not true hypogonadism, and it usually reverses when weight comes down (Muir et al., Journal of Clinical Endocrinology & Metabolism, 2025, DOI (external link)).

In women, current hormone therapy use is linked to less visceral fat in observational data. In that same cross-sectional study, users had no more lean mass than never-users, and HRT isn't a weight-loss treatment (Papadakis et al., OsteoLaus cohort, Journal of Clinical Endocrinology & Metabolism, 2018, DOI (external link)).

Some people use a GLP-1 for weight and HRT for hormone symptoms, under medical supervision. Evidence on combining them is thin. The main study so far is a small retrospective Mayo Clinic cohort in which postmenopausal women on semaglutide who also used hormone therapy lost more weight at 12 months (Hurtado et al., Menopause, 2024, DOI (external link)). Decisions are made case by case.

Muscle is the concern for everyone. GLP-1 weight loss can cost lean mass, and protein plus resistance training is the main protection (see why strength training matters on a GLP-1).

How to approach it

Get tested and properly diagnosed before starting any hormone therapy. This matters most for men, because obesity can make testosterone look low on a lab test. Then plan the GLP-1 and HRT decisions together with your clinician, since they treat different problems in the same person. And don't use HRT as a way to lose weight or as a stand-in for a GLP-1. That isn't what it does.

Study findings above are attributed to their authors and were located via PubMed.

This is general education, not medical advice. Hormone therapy carries individual benefits and risks, and decisions belong with your clinician.

hrthormone-therapyglp-1overview

Common questions

Questions people often ask about this topic.

  • Is HRT a weight-loss treatment?

    No. HRT (menopausal hormone therapy for women, testosterone therapy for men) replaces a hormone the body is short on. It isn't a weight-loss drug and doesn't work like a GLP-1, though people often consider it at the same stage of life when weight and body composition change.

  • How are HRT and GLP-1 medications related?

    They work on overlapping problems. Menopause and obesity-related low testosterone both tend to add fat and cost muscle, which a GLP-1 addresses through weight loss. Weight loss itself also changes hormones: in men with obesity, it tends to raise testosterone, including on GLP-1s. But one can't replace the other.

  • Should men and women approach HRT differently with a GLP-1?

    Yes. For women it's mainly about menopausal symptoms and bone protection. For men it's about whether low testosterone is true hypogonadism or the reversible, obesity-related kind. See the dedicated pages for each.

  • Do I need testing before combining HRT and a GLP-1?

    Yes. Get tested and properly diagnosed before starting any hormone therapy, especially if you're a man, since obesity can make testosterone look low on a lab test. Then plan the GLP-1 and HRT decisions together with your clinician.

Evidence

The sources behind this article, labeled by type and strength.

Supporting6

Mixed findings2

Revision history

Updated 4 times since Sep 2, 2026 · show changes
  1. v5

    Body revised

  2. v4

    Evidence sources 4 → 8

  3. v3

    Common questions revised

  4. v2

    Summary rewritten; Body revised

  5. v1

    Change tracking began

Related guides

  • HRT for women and GLP-1 medications: menopause, weight, and body composition · Menopause shifts where the body stores fat and how well it holds muscle, the same ground a GLP-1 works on, so hormone therapy often comes up. This guide explains what HRT is for women, who benefits, the 2025–2026 FDA label changes, and how HRT does and doesn't overlap with GLP-1 weight management.
  • Cortisol, stress, and weight on a GLP-1: what the connection really is · The "cortisol makes you fat" story is mostly overstated. Real cortisol excess, as in Cushing's syndrome, clearly drives central fat, but everyday stress does far less. On a GLP-1, cortisol matters more for muscle than for belly fat. This guide covers the evidence, how sleep affects cortisol, and why "cortisol-blocker" supplements don't hold up.
  • HRT for men (testosterone) and GLP-1 medications: what the connection really is · Low testosterone and excess weight are linked, but the cause often runs from the weight to the testosterone, and that changes when testosterone therapy actually helps. This guide covers who benefits from TRT and why losing weight on a GLP-1 can raise testosterone on its own.
  • CPAP as the weight comes off: managing sleep apnea on a GLP-1 · Tirzepatide (Zepbound) roughly halved sleep apnea severity in the SURMOUNT-OSA trials, and 42 to 50% of participants reached the trial's definition of resolution. That still left many with apnea, and the trials never tested stopping CPAP for good. This guide covers why you shouldn't retire your machine on your own, how pressure and mask fit change as weight comes off, when and how a repeat sleep test happens, and how an OSA diagnosis affects Zepbound coverage (as of September 2026).
  • Protecting your bones on a GLP-1: bone density, fracture risk, and what actually helps · Losing a lot of weight usually costs a small amount of bone, mostly at the hip, and GLP-1 weight loss is no exception. So far the fracture data are reassuring and the drug itself does not look like the main cause, but the long-term evidence is thin. Here's what the bone-density and fracture studies show, who should pay the most attention, and the levers that kept bone steady in trials: resistance and impact training, protein, calcium and vitamin D, and a well-timed bone scan.
  • Physician's Choice Digestive Enzymes & 60 Billion Probiotic: are they worth it on a GLP-1? · Physician's Choice markets these two supplements together in a "Hack Your Tummy" TikTok campaign for bloating and post-meal discomfort, a real complaint for GLP-1 users. Both score 54/100 (Skip). The GI need is real, but neither label discloses per-ingredient doses (for the probiotic, per-strain CFU), the certifications cited describe the factory rather than the product, and you pay a premium for formulas you can't check against the research.

Related terms

  • Hormone replacement therapy (HRT) · Treatment that replaces a hormone the body no longer produces in adequate amounts — most commonly estrogen (usually with a progestogen) for menopausal women, or testosterone for men with hypogonadism. It is not a weight-loss treatment and is separate from GLP-1 medications.
  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • Testosterone replacement therapy (TRT) · Replacing testosterone in men who have hypogonadism (clinically low testosterone plus symptoms), delivered as a gel, injection, patch, or pellet. It is for a specific diagnosis, not a default treatment for the reversible low testosterone that often accompanies obesity.
  • Menopausal hormone therapy (MHT) · Estrogen, usually combined with a progestogen (when the uterus is present), used to relieve menopausal symptoms such as hot flashes and to protect bone. Often just called 'HRT.' It is associated with less visceral fat but is not a weight-loss treatment.
  • Progestogen · A hormone — natural progesterone or a synthetic progestin — given alongside estrogen in menopausal hormone therapy to protect the lining of the uterus.
  • Hypogonadism · A condition of low sex-hormone production. In men it means low testosterone with symptoms; importantly, the low testosterone that often accompanies obesity is frequently a reversible state ('pseudo-hypogonadism') rather than true, pathologic hypogonadism.
  • Visceral fat · Fat stored deep in the abdomen around the internal organs, which is more strongly tied to metabolic and cardiovascular risk than fat under the skin.
  • LH and FSH · Luteinizing hormone and follicle-stimulating hormone: two pituitary hormones that signal the testes and ovaries to make sex hormones and sperm or eggs.

Was this helpful?

Improve this page